During the past decade, California Medical Research Associates Inc. conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 12 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Medical Research Associates Inc." #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Gan and Lee Pharmaceuticals, USA" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Bellus Health Inc" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Medical Research Associates Inc." #1 collaborator was "Integrium" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Mylan GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "California Medical Research Associates Inc." are "Diabetes Mellitus, Type 1" (3 trials), "Ulcerative Colitis" (3 trials), "Cardiovascular Disease" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "California Medical Research Associates Inc." in a lesser frequency.

Most popular intervention types in "California Medical Research Associates Inc." are "Drug" (22 trials), "Biological" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Mirikizumab" (3 trials), "Gan & Lee Insulin Glargine Injection" (2 trials), "Lantus®" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "California Medical Research Associates Inc." are 26 trials for "All" genders.

Currently, there are NaN active trials in "California Medical Research Associates Inc.". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in California Medical Research Associates Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in California Medical Research Associates Inc., 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".